US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

6.26

+0.17002.79%

Post-market: 6.260.00000.00%18:47 EST

Volume:520.60K

Turnover:3.29M

Market Cap:114.62M

PE:-0.43

High:6.66

Open:6.22

Low:6.00

Close:6.09

52wk High:10.38

52wk Low:3.51

Shares:18.31M

Float Shares:16.00M

Volume Ratio:1.35

T/O Rate:3.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.6151

EPS(LYR):-14.0039

ROE:-891.05%

ROA:-45.56%

PB:-0.43

PE(LYR):-0.45

Loading ...

Overview Company News Filings

Karyopharm Therapeutics Initiated at Overweight by Cantor Fitzgerald

Karyopharm Therapeutics Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht

Karyopharm initiated with an Overweight at Cantor Fitzgerald

BRIEF-Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

Karyopharm Therapeutics Grants RSUs to New Employees Under Inducement Plan

Kristin Abate, Chief Accounting Officer, Reports Sale of Karyopharm Therapeutics Inc. Common Shares

Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)

RBC Raises Price Target on Karyopharm Therapeutics to $23 From $19, Keeps Outperform Rating

MT Newswires Live

Karyopharm Therapeutics Releases Updated Corporate Presentation

Karyopharm sees FY25 revenue $145M, consensus $147.83M

Karyopharm Therapeutics Showcases Pipeline Progress and Selinexor Phase 3 Trial Milestones in Corporate Presentation

Karyopharm Therapeutics forecasts 2025 revenue of $145 million with $115 million from XPOVIO sales

Karyopharm Therapeutics Inc - 2025 Revenue Expected at $145 Mln, U.S. Xpovio Revenue at $115 Mln

THOMSON REUTERS

Press Release: Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026

Karyopharm Therapeutics Inc. Announces Date for Upcoming Special Stockholders Meeting

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Karyopharm Therapeutics Grants RSUs to New Employees Under Inducement Plan

Karyopharm Therapeutics Inc. Announces Date for Special Stockholders Meeting

Karyopharm Therapeutics Joins Baird's Biotech Discovery Series Fireside Chat

Karyopharm Therapeutics Grants Stock Options and RSUs to New Employees

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KPTI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"KPTI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KPTI\",,,,,undefined,":{"symbol":"KPTI","market":"US","secType":"STK","nameCN":"Karyopharm Therapeutics","latestPrice":6.26,"timestamp":1770411600000,"preClose":6.09,"halted":0,"volume":520595,"hourTrading":{"tag":"盘后","latestPrice":6.26,"preClose":6.26,"latestTime":"18:47 EST","volume":1498,"amount":9375.6398,"timestamp":1770421633102,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.027914614121510663,"floatShares":16000500,"shares":18310300,"eps":-14.615059,"marketStatus":"Not Yet Opened","change":0.17,"latestTime":"02-06 16:00:00 EST","open":6.22,"high":6.6596,"low":6,"amount":3293446.6559375003,"amplitude":0.108309,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.615059,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1383714000000,"exchange":"NASDAQ","adjPreClose":6.09,"preHourTrading":{"tag":"盘前","latestPrice":6.35,"preClose":6.09,"latestTime":"08:00 EST","volume":315,"amount":2000.25,"timestamp":1770382806980,"change":0.26,"changeRate":0.042693,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":6.26,"preClose":6.26,"latestTime":"18:47 EST","volume":1498,"amount":9375.6398,"timestamp":1770421633102,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3468723850884297,"impliedVol":2.4725,"impliedVolPercentile":0.7952},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KPTI\",,,,,undefined,":{"symbol":"KPTI","floatShares":16000500,"roa":"-45.56%","roe":"-891.05%","lyrEps":-14.003887,"volumeRatio":1.3468723850884297,"shares":18310300,"dividePrice":0,"high":6.6596,"amplitude":0.108309,"preClose":6.09,"low":6,"week52Low":3.51,"pbRate":"-0.43","psRate":"0.80","week52High":10.38,"institutionHeld":0,"latestPrice":6.26,"eps":-14.615059,"divideRate":0,"volume":520595,"delay":0,"ttmEps":-14.615059,"open":6.22,"prevYearClose":7.36,"prevWeekClose":6.52,"prevMonthClose":6.52,"prevQuarterClose":7.36,"fiveDayClose":6.52,"twentyDayClose":8.17,"sixtyDayClose":5.44,"earningDate":1770825600000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KPTI\",params:#limit:5,,,undefined,":[{"date":"2026-02-12","symbol":"KPTI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-2.26,"defaultRemindTime":1770886800000,"name":null,"time":"Pre-Market","dateTimestamp":1770872400000,"actualEps":null},{"date":"2026-01-12","symbol":"KPTI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768208400000,"name":null,"time":"Pre-Market","dateTimestamp":1768194000000,"actualEps":null},{"market":"US","date":"2025-11-03","symbol":"KPTI","fiscalQuarterEnding":"2025/09","expectedEps":-3.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762146000000,"reportTimeType":"pre","actualEps":-3.82},{"date":"2025-10-08","symbol":"KPTI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1759910400000,"name":null,"time":"Pre-Market","dateTimestamp":1759896000000,"actualEps":null},{"market":"US","date":"2025-08-11","symbol":"KPTI","fiscalQuarterEnding":"2025/06","expectedEps":-3.8,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-4.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KPTI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KPTI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1762318800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KPTI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KPTI","date":"2026-02-06","current":-0.428325,"percent":0.735987,"low":-8.777863,"twenty":-3.785183,"median":-1.314386,"eighty":-0.768355,"high":-0.264561,"avg":-2.131365,"sd":1.531567,"marketCap":111509623},"quantilePoints":[{"date":"2021-02-12","current":-5.732363,"twenty":-6.177382,"median":-4.284028,"eighty":-3.19818,"marketCap":1125108060},{"date":"2021-02-19","current":-5.690933,"twenty":-6.177382,"median":-4.31069,"eighty":-3.203494,"marketCap":1116976530},{"date":"2021-02-26","current":-5.255159,"twenty":-6.177382,"median":-4.36136,"eighty":-3.203494,"marketCap":1031445901},{"date":"2021-03-05","current":-4.422395,"twenty":-6.178113,"median":-4.391958,"eighty":-3.201478,"marketCap":867996804},{"date":"2021-03-12","current":-4.68097,"twenty":-6.178113,"median":-4.389108,"eighty":-3.201478,"marketCap":918748122},{"date":"2021-03-19","current":-4.585906,"twenty":-6.178113,"median":-4.389108,"eighty":-3.201478,"marketCap":900089549},{"date":"2021-03-26","current":-3.916653,"twenty":-6.177382,"median":-4.364548,"eighty":-3.203494,"marketCap":768733197},{"date":"2021-04-01","current":-4.121992,"twenty":-6.177382,"median":-4.347819,"eighty":-3.203494,"marketCap":809035714},{"date":"2021-04-09","current":-3.831989,"twenty":-6.178113,"median":-4.284028,"eighty":-3.201478,"marketCap":752115969},{"date":"2021-04-16","current":-3.713434,"twenty":-6.178113,"median":-4.267941,"eighty":-3.201478,"marketCap":728846912},{"date":"2021-04-23","current":-3.591056,"twenty":-6.178113,"median":-4.251696,"eighty":-3.201478,"marketCap":704827240},{"date":"2021-04-30","current":-3.571934,"twenty":-6.178113,"median":-4.239571,"eighty":-3.201478,"marketCap":701074167},{"date":"2021-05-07","current":-3.140141,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":630402099},{"date":"2021-05-14","current":-3.433769,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":689349765},{"date":"2021-05-21","current":-3.523541,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":707371981},{"date":"2021-05-28","current":-3.471174,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":696859021},{"date":"2021-06-04","current":-3.351478,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":672829400},{"date":"2021-06-11","current":-3.860185,"twenty":-6.178113,"median":-4.217056,"eighty":-3.179489,"marketCap":774955291},{"date":"2021-06-18","current":-3.957438,"twenty":-6.178113,"median":-4.217056,"eighty":-3.182199,"marketCap":794479358},{"date":"2021-06-25","current":-4.110798,"twenty":-6.178113,"median":-4.217056,"eighty":-3.208068,"marketCap":825267311},{"date":"2021-07-02","current":-3.931254,"twenty":-6.178113,"median":-4.217056,"eighty":-3.226571,"marketCap":789222879},{"date":"2021-07-09","current":-3.762932,"twenty":-6.178113,"median":-4.217056,"eighty":-3.239573,"marketCap":755431224},{"date":"2021-07-16","current":-3.459953,"twenty":-6.178113,"median":-4.217056,"eighty":-3.263434,"marketCap":694606244},{"date":"2021-07-23","current":-3.306593,"twenty":-6.178113,"median":-4.217056,"eighty":-3.285844,"marketCap":663818292},{"date":"2021-07-30","current":-3.115828,"twenty":-6.178113,"median":-4.217056,"eighty":-3.286193,"marketCap":625521083},{"date":"2021-08-06","current":-2.004429,"twenty":-6.178113,"median":-4.217056,"eighty":-3.286193,"marketCap":416744869},{"date":"2021-08-13","current":-1.772032,"twenty":-6.178113,"median":-4.217056,"eighty":-3.286193,"marketCap":368426623},{"date":"2021-08-20","current":-1.681251,"twenty":-6.178113,"median":-4.217056,"eighty":-3.286193,"marketCap":349552309},{"date":"2021-08-27","current":-2.033479,"twenty":-6.178113,"median":-4.217056,"eighty":-3.286193,"marketCap":422784650},{"date":"2021-09-03","current":-2.069791,"twenty":-6.178113,"median":-4.217056,"eighty":-3.26987,"marketCap":430334376},{"date":"2021-09-10","current":-2.102472,"twenty":-6.178113,"median":-4.217056,"eighty":-3.26987,"marketCap":437129129},{"date":"2021-09-17","current":-2.204146,"twenty":-6.178113,"median":-4.217056,"eighty":-3.26987,"marketCap":458268362},{"date":"2021-09-24","current":-2.273139,"twenty":-6.178113,"median":-4.217056,"eighty":-3.263434,"marketCap":472612841},{"date":"2021-10-01","current":-2.142415,"twenty":-6.178113,"median":-4.217056,"eighty":-3.244364,"marketCap":445433828},{"date":"2021-10-08","current":-2.069791,"twenty":-6.178113,"median":-4.217056,"eighty":-3.226402,"marketCap":430334376},{"date":"2021-10-15","current":-2.029848,"twenty":-6.178113,"median":-4.217056,"eighty":-3.210185,"marketCap":422029677},{"date":"2021-10-22","current":-1.913649,"twenty":-6.178113,"median":-4.217056,"eighty":-3.210185,"marketCap":397870554},{"date":"2021-10-29","current":-1.982642,"twenty":-6.178113,"median":-4.217056,"eighty":-3.210185,"marketCap":412215034},{"date":"2021-11-05","current":-3.08082,"twenty":-6.178113,"median":-4.217056,"eighty":-3.210185,"marketCap":635354458},{"date":"2021-11-12","current":-3.110126,"twenty":-6.178113,"median":-4.217056,"eighty":-3.191989,"marketCap":641398258},{"date":"2021-11-19","current":-2.773104,"twenty":-6.178113,"median":-4.217056,"eighty":-3.171935,"marketCap":571894559},{"date":"2021-11-26","current":-2.663206,"twenty":-6.178113,"median":-4.217056,"eighty":-3.152248,"marketCap":549230310},{"date":"2021-12-03","current":-2.461725,"twenty":-6.178113,"median":-4.217056,"eighty":-3.122043,"marketCap":507679186},{"date":"2021-12-10","current":-2.194306,"twenty":-6.178113,"median":-4.217056,"eighty":-3.077558,"marketCap":452529513},{"date":"2021-12-17","current":-2.252918,"twenty":-6.178113,"median":-4.217056,"eighty":-3.041599,"marketCap":464617112},{"date":"2021-12-23","current":-2.692512,"twenty":-6.178113,"median":-4.217056,"eighty":-3.015867,"marketCap":555274110},{"date":"2021-12-31","current":-2.35549,"twenty":-6.178113,"median":-4.217056,"eighty":-2.991773,"marketCap":485770412},{"date":"2022-01-07","current":-2.586277,"twenty":-6.177382,"median":-4.216189,"eighty":-2.951041,"marketCap":533365335},{"date":"2022-01-14","current":-2.945279,"twenty":-6.177382,"median":-4.216189,"eighty":-2.925652,"marketCap":607401883},{"date":"2022-01-21","current":-3.033197,"twenty":-6.177382,"median":-4.216189,"eighty":-2.908348,"marketCap":625533283},{"date":"2022-01-28","current":-3.128443,"twenty":-6.177382,"median":-4.216189,"eighty":-2.906995,"marketCap":645175632},{"date":"2022-02-04","current":-3.568037,"twenty":-6.177382,"median":-4.216189,"eighty":-2.906995,"marketCap":735832630},{"date":"2022-02-11","current":-6.238509,"twenty":-6.180304,"median":-4.234673,"eighty":-2.906995,"marketCap":774124120},{"date":"2022-02-18","current":-8.777863,"twenty":-6.208868,"median":-4.248181,"eighty":-2.906995,"marketCap":1089227480},{"date":"2022-02-25","current":-6.403323,"twenty":-6.240007,"median":-4.257032,"eighty":-2.906995,"marketCap":794575540},{"date":"2022-03-04","current":-3.770193,"twenty":-6.251665,"median":-4.26161,"eighty":-2.906995,"marketCap":467835694},{"date":"2022-03-11","current":-4.038125,"twenty":-6.251665,"median":-4.254328,"eighty":-2.906995,"marketCap":501082901},{"date":"2022-03-18","current":-4.58037,"twenty":-6.251665,"median":-4.26161,"eighty":-2.906995,"marketCap":568368914},{"date":"2022-03-25","current":-4.663301,"twenty":-6.251665,"median":-4.282008,"eighty":-2.906995,"marketCap":578659716},{"date":"2022-04-01","current":-5.141752,"twenty":-6.251665,"median":-4.29009,"eighty":-2.906995,"marketCap":638029728},{"date":"2022-04-08","current":-5.184068,"twenty":-6.251665,"median":-4.298174,"eighty":-2.906995,"marketCap":643280680},{"date":"2022-04-14","current":-4.992066,"twenty":-6.251665,"median":-4.351584,"eighty":-2.906995,"marketCap":619455470},{"date":"2022-04-22","current":-4.300857,"twenty":-6.251665,"median":-4.367129,"eighty":-2.906995,"marketCap":533684712},{"date":"2022-04-29","current":-3.904052,"twenty":-6.251665,"median":-4.367129,"eighty":-2.906995,"marketCap":484445944},{"date":"2022-05-06","current":-4.467939,"twenty":-6.251665,"median":-4.381025,"eighty":-2.906995,"marketCap":482863561},{"date":"2022-05-13","current":-3.924144,"twenty":-6.251665,"median":-4.381025,"eighty":-2.906995,"marketCap":424093983},{"date":"2022-05-20","current":-4.276876,"twenty":-6.251665,"median":-4.381025,"eighty":-2.906995,"marketCap":462214791},{"date":"2022-05-27","current":-4.688396,"twenty":-6.251665,"median":-4.393149,"eighty":-2.906995,"marketCap":506689066},{"date":"2022-06-03","current":-4.592865,"twenty":-6.251665,"median":-4.413146,"eighty":-2.906995,"marketCap":496364681},{"date":"2022-06-10","current":-4.041721,"twenty":-6.251665,"median":-4.422403,"eighty":-2.906995,"marketCap":436800919},{"date":"2022-06-17","current":-3.262771,"twenty":-6.251665,"median":-4.422403,"eighty":-2.906995,"marketCap":352617469},{"date":"2022-06-24","current":-3.799218,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":410592864},{"date":"2022-07-01","current":-3.47588,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":375648790},{"date":"2022-07-08","current":-3.858006,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":416946332},{"date":"2022-07-15","current":-3.461183,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":374060423},{"date":"2022-07-22","current":-3.27012,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":353411653},{"date":"2022-07-29","current":-3.123148,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":337527983},{"date":"2022-08-05","current":-3.6068,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":373494962},{"date":"2022-08-12","current":-4.169399,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":431753792},{"date":"2022-08-19","current":-4.21564,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":436542189},{"date":"2022-08-26","current":-3.945901,"twenty":-6.253625,"median":-4.431432,"eighty":-2.906836,"marketCap":408609873},{"date":"2022-09-02","current":-4.038383,"twenty":-6.253625,"median":-4.431432,"eighty":-2.906836,"marketCap":418186667},{"date":"2022-09-09","current":-4.123158,"twenty":-6.253625,"median":-4.431432,"eighty":-2.906836,"marketCap":426965395},{"date":"2022-09-16","current":-3.884246,"twenty":-6.253625,"median":-4.431329,"eighty":-2.906836,"marketCap":402225344},{"date":"2022-09-23","current":-3.391009,"twenty":-6.253625,"median":-4.42241,"eighty":-2.906836,"marketCap":351149110},{"date":"2022-09-30","current":-4.207933,"twenty":-6.253625,"median":-4.419107,"eighty":-2.906836,"marketCap":435744123},{"date":"2022-10-07","current":-4.269588,"twenty":-6.253625,"median":-4.407185,"eighty":-2.906836,"marketCap":442128652},{"date":"2022-10-14","current":-3.691575,"twenty":-6.253625,"median":-4.365357,"eighty":-2.906836,"marketCap":382273690},{"date":"2022-10-21","current":-3.506611,"twenty":-6.253625,"median":-4.320057,"eighty":-2.906836,"marketCap":363120102},{"date":"2022-10-28","current":-3.907367,"twenty":-6.253625,"median":-4.320057,"eighty":-2.906836,"marketCap":404619543},{"date":"2022-11-04","current":-4.368078,"twenty":-6.253625,"median":-4.300857,"eighty":-2.906836,"marketCap":384674823},{"date":"2022-11-11","current":-5.215891,"twenty":-6.253625,"median":-4.300857,"eighty":-2.906836,"marketCap":459337447},{"date":"2022-11-18","current":-4.580032,"twenty":-6.253625,"median":-4.300857,"eighty":-2.906836,"marketCap":403340479},{"date":"2022-11-25","current":-4.552385,"twenty":-6.253625,"median":-4.300857,"eighty":-2.906836,"marketCap":400905828},{"date":"2022-12-02","current":-4.745908,"twenty":-6.253625,"median":-4.300857,"eighty":-2.906836,"marketCap":417948383},{"date":"2022-12-09","current":-4.331217,"twenty":-6.253625,"median":-4.294457,"eighty":-2.906836,"marketCap":381428622},{"date":"2022-12-16","current":-2.85676,"twenty":-6.253625,"median":-4.284224,"eighty":-2.903809,"marketCap":251580580},{"date":"2022-12-23","current":-3.32961,"twenty":-6.253625,"median":-4.284224,"eighty":-2.862041,"marketCap":293222102},{"date":"2022-12-30","current":-4.370917,"twenty":-6.253625,"median":-4.294457,"eighty":-2.862041,"marketCap":384924767},{"date":"2023-01-06","current":-4.512329,"twenty":-6.253625,"median":-4.322002,"eighty":-2.862041,"marketCap":397378216},{"date":"2023-01-13","current":-4.24236,"twenty":-6.253625,"median":-4.320057,"eighty":-2.862041,"marketCap":373603451},{"date":"2023-01-20","current":-4.33235,"twenty":-6.253625,"median":-4.322002,"eighty":-2.862041,"marketCap":381528372},{"date":"2023-01-27","current":-4.088093,"twenty":-6.253625,"median":-4.294457,"eighty":-2.862041,"marketCap":360017871},{"date":"2023-02-03","current":-4.370917,"twenty":-6.253625,"median":-4.284224,"eighty":-2.862041,"marketCap":384924767},{"date":"2023-02-10","current":-4.165226,"twenty":-6.253625,"median":-4.269527,"eighty":-2.862041,"marketCap":366810661},{"date":"2023-02-17","current":-2.43428,"twenty":-6.240783,"median":-4.262179,"eighty":-2.84267,"marketCap":402364561},{"date":"2023-02-24","current":-2.057138,"twenty":-6.238604,"median":-4.24236,"eighty":-2.823533,"marketCap":340026390},{"date":"2023-03-03","current":-2.146281,"twenty":-6.180304,"median":-4.224661,"eighty":-2.781626,"marketCap":354760866},{"date":"2023-03-10","current":-2.057138,"twenty":-6.152907,"median":-4.208959,"eighty":-2.75484,"marketCap":340026390},{"date":"2023-03-17","current":-2.331423,"twenty":-6.11274,"median":-4.196041,"eighty":-2.706336,"marketCap":385363242},{"date":"2023-03-24","current":-2.276566,"twenty":-6.11274,"median":-4.183771,"eighty":-2.661741,"marketCap":376295871},{"date":"2023-03-31","current":-2.667422,"twenty":-6.111964,"median":-4.173741,"eighty":-2.649856,"marketCap":440900885},{"date":"2023-04-06","current":-2.681136,"twenty":-6.111964,"median":-4.146073,"eighty":-2.649856,"marketCap":443167728},{"date":"2023-04-14","current":-2.978326,"twenty":-6.11274,"median":-4.128054,"eighty":-2.647561,"marketCap":492290498},{"date":"2023-04-21","current":-2.619824,"twenty":-6.11274,"median":-4.108854,"eighty":-2.641981,"marketCap":433033309},{"date":"2023-04-28","current":-2.412996,"twenty":-6.11274,"median":-4.086917,"eighty":-2.626336,"marketCap":398846469},{"date":"2023-05-05","current":-1.997872,"twenty":-6.087907,"median":-4.049743,"eighty":-2.6213,"marketCap":315699670},{"date":"2023-05-12","current":-1.911983,"twenty":-6.00906,"median":-4.038383,"eighty":-2.601613,"marketCap":302127687},{"date":"2023-05-19","current":-1.738822,"twenty":-5.954697,"median":-4.012327,"eighty":-2.595069,"marketCap":274765179},{"date":"2023-05-26","current":-1.738822,"twenty":-5.924166,"median":-3.998811,"eighty":-2.559679,"marketCap":274765179},{"date":"2023-06-02","current":-1.587306,"twenty":-5.912525,"median":-3.987794,"eighty":-2.54416,"marketCap":250822985},{"date":"2023-06-09","current":-1.688317,"twenty":-5.903664,"median":-3.97614,"eighty":-2.515942,"marketCap":266784448},{"date":"2023-06-16","current":-1.493511,"twenty":-5.881585,"median":-3.961315,"eighty":-2.495534,"marketCap":236001627},{"date":"2023-06-23","current":-1.464651,"twenty":-5.820152,"median":-3.946448,"eighty":-2.476356,"marketCap":231441209},{"date":"2023-06-30","current":-1.32035,"twenty":-5.781367,"median":-3.938194,"eighty":-2.46815,"marketCap":208639119},{"date":"2023-07-07","current":-1.096684,"twenty":-5.767239,"median":-3.926795,"eighty":-2.461725,"marketCap":173295880},{"date":"2023-07-14","current":-1.183265,"twenty":-5.753441,"median":-3.916124,"eighty":-2.45079,"marketCap":186977134},{"date":"2023-07-21","current":-1.16162,"twenty":-5.738623,"median":-3.902098,"eighty":-2.423309,"marketCap":183556821},{"date":"2023-07-28","current":-1.21934,"twenty":-5.710966,"median":-3.89966,"eighty":-2.39588,"marketCap":192677657},{"date":"2023-08-04","current":-1.46188,"twenty":-5.691895,"median":-3.884246,"eighty":-2.372906,"marketCap":206981717},{"date":"2023-08-11","current":-1.348806,"twenty":-5.675808,"median":-3.862584,"eighty":-2.346821,"marketCap":190972081},{"date":"2023-08-18","current":-1.356883,"twenty":-5.661094,"median":-3.856444,"eighty":-2.327554,"marketCap":192115627},{"date":"2023-08-25","current":-1.122659,"twenty":-5.642939,"median":-3.835297,"eighty":-2.279163,"marketCap":158952810},{"date":"2023-09-01","current":-1.033816,"twenty":-5.621148,"median":-3.822591,"eighty":-2.226817,"marketCap":146373811},{"date":"2023-09-08","current":-0.936895,"twenty":-5.610619,"median":-3.805269,"eighty":-2.211408,"marketCap":132651266},{"date":"2023-09-15","current":-1.049969,"twenty":-5.594688,"median":-3.791764,"eighty":-2.194285,"marketCap":148660902},{"date":"2023-09-22","current":-1.009586,"twenty":-5.573404,"median":-3.784057,"eighty":-2.163015,"marketCap":142943175},{"date":"2023-09-29","current":-1.106506,"twenty":-5.553533,"median":-3.768644,"eighty":-2.142415,"marketCap":156665719},{"date":"2023-10-06","current":-1.058046,"twenty":-5.535997,"median":-3.751711,"eighty":-2.124259,"marketCap":149804447},{"date":"2023-10-13","current":-1.009586,"twenty":-5.530362,"median":-3.745537,"eighty":-2.113365,"marketCap":142943175},{"date":"2023-10-20","current":-0.856129,"twenty":-5.528881,"median":-3.711035,"eighty":-2.099567,"marketCap":121215812},{"date":"2023-10-27","current":-0.647104,"twenty":-5.530246,"median":-3.695288,"eighty":-2.090126,"marketCap":91620857},{"date":"2023-11-03","current":-0.622876,"twenty":-5.530246,"median":-3.680928,"eighty":-2.070428,"marketCap":87058111},{"date":"2023-11-10","current":-0.56813,"twenty":-5.530246,"median":-3.667547,"eighty":-2.054937,"marketCap":79406415},{"date":"2023-11-17","current":-0.570752,"twenty":-5.530246,"median":-3.644676,"eighty":-2.02705,"marketCap":79772924},{"date":"2023-11-24","current":-0.605088,"twenty":-5.530246,"median":-3.63006,"eighty":-2.008787,"marketCap":84571898},{"date":"2023-12-01","current":-0.630983,"twenty":-5.530246,"median":-3.594199,"eighty":-1.984272,"marketCap":88191173},{"date":"2023-12-08","current":-0.687115,"twenty":-5.530188,"median":-3.575973,"eighty":-1.952485,"marketCap":96036751},{"date":"2023-12-15","current":-0.688509,"twenty":-5.530188,"median":-3.560803,"eighty":-1.928904,"marketCap":96231459},{"date":"2023-12-22","current":-0.62328,"twenty":-5.530188,"median":-3.557127,"eighty":-1.913316,"marketCap":87114553},{"date":"2023-12-29","current":-0.756605,"twenty":-5.530246,"median":-3.558965,"eighty":-1.898992,"marketCap":105749233},{"date":"2024-01-05","current":-0.676053,"twenty":-5.530304,"median":-3.549366,"eighty":-1.893314,"marketCap":94490542},{"date":"2024-01-12","current":-0.604924,"twenty":-5.530304,"median":-3.523541,"eighty":-1.878246,"marketCap":84548992},{"date":"2024-01-19","current":-0.593206,"twenty":-5.530362,"median":-3.503855,"eighty":-1.861175,"marketCap":82911156},{"date":"2024-01-26","current":-0.717599,"twenty":-5.530304,"median":-3.501098,"eighty":-1.83927,"marketCap":100297415},{"date":"2024-02-02","current":-0.737758,"twenty":-5.530304,"median":-3.501098,"eighty":-1.821001,"marketCap":103114952},{"date":"2024-02-09","current":-1.237381,"twenty":-5.530304,"median":-3.501098,"eighty":-1.803757,"marketCap":172946326},{"date":"2024-02-16","current":-1.065295,"twenty":-5.530304,"median":-3.497357,"eighty":-1.784998,"marketCap":148894188},{"date":"2024-02-23","current":-0.925987,"twenty":-5.530304,"median":-3.493617,"eighty":-1.76886,"marketCap":129423409},{"date":"2024-03-01","current":-0.931533,"twenty":-5.530246,"median":-3.493617,"eighty":-1.765064,"marketCap":133301400},{"date":"2024-03-08","current":-1.230286,"twenty":-5.530246,"median":-3.493617,"eighty":-1.765064,"marketCap":176052636},{"date":"2024-03-15","current":-1.077505,"twenty":-5.530246,"median":-3.493617,"eighty":-1.765064,"marketCap":154189891},{"date":"2024-03-22","current":-1.141834,"twenty":-5.530246,"median":-3.493617,"eighty":-1.75222,"marketCap":163395257},{"date":"2024-03-28","current":-1.19008,"twenty":-5.530246,"median":-3.493617,"eighty":-1.741713,"marketCap":170299282},{"date":"2024-04-05","current":-1.069464,"twenty":-5.530304,"median":-3.493617,"eighty":-1.717331,"marketCap":153039220},{"date":"2024-04-12","current":-1.077505,"twenty":-5.530304,"median":-3.493617,"eighty":-1.708028,"marketCap":154189891},{"date":"2024-04-19","current":-1.041769,"twenty":-5.530304,"median":-3.493617,"eighty":-1.692185,"marketCap":149076142},{"date":"2024-04-26","current":-0.862715,"twenty":-5.530246,"median":-3.493617,"eighty":-1.684206,"marketCap":123453680},{"date":"2024-05-03","current":-0.878993,"twenty":-5.530246,"median":-3.493617,"eighty":-1.684206,"marketCap":125782994},{"date":"2024-05-10","current":-0.860696,"twenty":-5.530246,"median":-3.493617,"eighty":-1.684206,"marketCap":125949981},{"date":"2024-05-17","current":-0.912982,"twenty":-5.530246,"median":-3.493617,"eighty":-1.684206,"marketCap":133601148},{"date":"2024-05-24","current":-0.876784,"twenty":-5.530246,"median":-3.493617,"eighty":-1.679677,"marketCap":128304186},{"date":"2024-05-31","current":-0.807467,"twenty":-5.530246,"median":-3.493617,"eighty":-1.663086,"marketCap":118160637},{"date":"2024-06-07","current":-0.828501,"twenty":-5.530246,"median":-3.493617,"eighty":-1.652426,"marketCap":121238645},{"date":"2024-06-14","current":-0.86861,"twenty":-5.530304,"median":-3.493617,"eighty":-1.621772,"marketCap":127108046},{"date":"2024-06-21","current":-0.807575,"twenty":-5.530362,"median":-3.495487,"eighty":-1.552674,"marketCap":118176450},{"date":"2024-06-28","current":-0.828782,"twenty":-5.531765,"median":-3.501098,"eighty":-1.502169,"marketCap":121279797},{"date":"2024-07-05","current":-0.705372,"twenty":-5.531765,"median":-3.501098,"eighty":-1.463543,"marketCap":103220561},{"date":"2024-07-12","current":-0.819669,"twenty":-5.531765,"median":-3.501098,"eighty":-1.430073,"marketCap":119946230},{"date":"2024-07-15","current":-0.803572,"twenty":-5.531765,"median":-3.501098,"eighty":-1.408574,"marketCap":117590677},{"date":"2024-08-02","current":-0.786708,"twenty":-5.540395,"median":-3.52844,"eighty":-1.378071,"marketCap":115122956},{"date":"2024-08-09","current":-1.162622,"twenty":-5.540395,"median":-3.52844,"eighty":-1.348806,"marketCap":104534798},{"date":"2024-08-16","current":-1.156659,"twenty":-5.540395,"median":-3.52844,"eighty":-1.300346,"marketCap":103998658},{"date":"2024-08-23","current":-1.091622,"twenty":-5.540395,"median":-3.52844,"eighty":-1.26245,"marketCap":98150993},{"date":"2024-08-30","current":-1.06888,"twenty":-5.540395,"median":-3.52844,"eighty":-1.237381,"marketCap":96106181},{"date":"2024-09-06","current":-1.106182,"twenty":-5.540395,"median":-3.52844,"eighty":-1.214203,"marketCap":99460172},{"date":"2024-09-13","current":-1.020345,"twenty":-5.540395,"median":-3.52844,"eighty":-1.19008,"marketCap":91742252},{"date":"2024-09-20","current":-1.024921,"twenty":-5.540395,"median":-3.52844,"eighty":-1.179196,"marketCap":92153708},{"date":"2024-09-27","current":-0.979714,"twenty":-5.540395,"median":-3.52844,"eighty":-1.162622,"marketCap":88089020},{"date":"2024-10-04","current":-1.221696,"twenty":-5.540395,"median":-3.52844,"eighty":-1.156659,"marketCap":109846322},{"date":"2024-10-11","current":-1.174547,"twenty":-5.540395,"median":-3.52844,"eighty":-1.156659,"marketCap":105607077},{"date":"2024-10-18","current":-1.184254,"twenty":-5.540395,"median":-3.52844,"eighty":-1.156659,"marketCap":106479863},{"date":"2024-10-25","current":-1.131559,"twenty":-5.540395,"median":-3.52844,"eighty":-1.155827,"marketCap":101741883},{"date":"2024-10-31","current":-1.165118,"twenty":-5.540395,"median":-3.52844,"eighty":-1.155436,"marketCap":104759228},{"date":"2024-11-08","current":-1.26376,"twenty":-5.541296,"median":-3.5198,"eighty":-1.15523,"marketCap":110552457},{"date":"2024-11-15","current":-1.19944,"twenty":-5.541296,"median":-3.493617,"eighty":-1.15523,"marketCap":104925835},{"date":"2024-11-22","current":-1.113919,"twenty":-5.541296,"median":-3.47588,"eighty":-1.14719,"marketCap":97444559},{"date":"2024-11-29","current":-1.210614,"twenty":-5.541296,"median":-3.463693,"eighty":-1.14719,"marketCap":105903289},{"date":"2024-12-06","current":-1.140851,"twenty":-5.541296,"median":-3.43751,"eighty":-1.145928,"marketCap":99800472},{"date":"2024-12-13","current":-1.037137,"twenty":-5.541296,"median":-3.414129,"eighty":-1.13842,"marketCap":90727702},{"date":"2024-12-20","current":-0.930558,"twenty":-5.537319,"median":-3.387697,"eighty":-1.128401,"marketCap":81404303},{"date":"2024-12-27","current":-0.859506,"twenty":-5.530188,"median":-3.36644,"eighty":-1.123123,"marketCap":75188703},{"date":"2025-01-03","current":-1.162625,"twenty":-5.516937,"median":-3.343606,"eighty":-1.121478,"marketCap":101705253},{"date":"2025-01-10","current":-1.025677,"twenty":-5.508837,"median":-3.312909,"eighty":-1.11771,"marketCap":89725186},{"date":"2025-01-17","current":-1.007316,"twenty":-5.497414,"median":-3.305436,"eighty":-1.112429,"marketCap":88118996},{"date":"2025-01-24","current":-0.992746,"twenty":-5.497414,"median":-3.273794,"eighty":-1.107,"marketCap":86844470},{"date":"2025-01-31","current":-0.957982,"twenty":-5.497414,"median":-3.261546,"eighty":-1.105896,"marketCap":83803273},{"date":"2025-02-07","current":-0.94774,"twenty":-5.497414,"median":-3.175832,"eighty":-1.099644,"marketCap":82907318},{"date":"2025-02-14","current":-0.879508,"twenty":-5.497414,"median":-3.156988,"eighty":-1.094654,"marketCap":76938496},{"date":"2025-02-21","current":-1.007647,"twenty":-5.497414,"median":-3.135466,"eighty":-1.083557,"marketCap":77006432},{"date":"2025-02-28","current":-0.919547,"twenty":-5.497414,"median":-3.112977,"eighty":-1.076519,"marketCap":70273658},{"date":"2025-03-07","current":-0.68498,"twenty":-5.459269,"median":-3.063461,"eighty":-1.066729,"marketCap":52347563},{"date":"2025-03-14","current":-0.764271,"twenty":-5.377449,"median":-3.033537,"eighty":-1.058663,"marketCap":58407088},{"date":"2025-03-21","current":-0.67617,"twenty":-5.323498,"median":-2.978326,"eighty":-1.050101,"marketCap":51674282},{"date":"2025-03-28","current":-0.479046,"twenty":-5.224446,"median":-2.945279,"eighty":-1.041892,"marketCap":36609630},{"date":"2025-04-04","current":-0.425084,"twenty":-5.182452,"median":-2.90636,"eighty":-1.037854,"marketCap":32485787},{"date":"2025-04-11","current":-0.439401,"twenty":-5.097768,"median":-2.855494,"eighty":-1.033601,"marketCap":33579867},{"date":"2025-04-17","current":-0.486754,"twenty":-4.988131,"median":-2.820242,"eighty":-1.024311,"marketCap":37198750},{"date":"2025-04-25","current":-0.657449,"twenty":-4.90474,"median":-2.783037,"eighty":-1.019651,"marketCap":50243561},{"date":"2025-05-02","current":-0.758085,"twenty":-4.802193,"median":-2.732808,"eighty":-1.010806,"marketCap":57934396},{"date":"2025-05-09","current":-0.689678,"twenty":-4.756262,"median":-2.687994,"eighty":-1.007448,"marketCap":52706588},{"date":"2025-05-16","current":-0.745686,"twenty":-4.690954,"median":-2.666869,"eighty":-1.002814,"marketCap":46621762},{"date":"2025-05-23","current":-0.641201,"twenty":-4.668631,"median":-2.639443,"eighty":-0.991544,"marketCap":40089154},{"date":"2025-05-30","current":-0.626,"twenty":-4.606093,"median":-2.61192,"eighty":-0.988921,"marketCap":39138765},{"date":"2025-06-06","current":-0.588689,"twenty":-4.57934,"median":-2.571624,"eighty":-0.98354,"marketCap":36805991},{"date":"2025-06-13","current":-0.602508,"twenty":-4.544148,"median":-2.497361,"eighty":-0.976077,"marketCap":37669981},{"date":"2025-06-20","current":-0.613563,"twenty":-4.525095,"median":-2.464938,"eighty":-0.968885,"marketCap":38361173},{"date":"2025-06-27","current":-0.620472,"twenty":-4.496165,"median":-2.44341,"eighty":-0.961125,"marketCap":38793168},{"date":"2025-07-03","current":-0.606653,"twenty":-4.462711,"median":-2.413709,"eighty":-0.955525,"marketCap":37929178},{"date":"2025-07-11","current":-0.690949,"twenty":-4.419353,"median":-2.38628,"eighty":-0.94965,"marketCap":43199520},{"date":"2025-07-18","current":-0.562433,"twenty":-4.370917,"median":-2.350313,"eighty":-0.944972,"marketCap":35164409},{"date":"2025-07-25","current":-0.612181,"twenty":-4.34425,"median":-2.283059,"eighty":-0.930753,"marketCap":38274774},{"date":"2025-08-01","current":-0.526503,"twenty":-4.321613,"median":-2.22019,"eighty":-0.921603,"marketCap":32918034},{"date":"2025-08-08","current":-0.548614,"twenty":-4.291871,"median":-2.206071,"eighty":-0.917005,"marketCap":34300418},{"date":"2025-08-15","current":-0.326315,"twenty":-4.268071,"median":-2.187423,"eighty":-0.909097,"marketCap":40321442},{"date":"2025-08-22","current":-0.422455,"twenty":-4.25249,"median":-2.149795,"eighty":-0.897627,"marketCap":52201093},{"date":"2025-08-29","current":-0.538946,"twenty":-4.228811,"median":-2.135675,"eighty":-0.890144,"marketCap":66595415},{"date":"2025-09-05","current":-0.47263,"twenty":-4.21564,"median":-2.12104,"eighty":-0.879508,"marketCap":58401057},{"date":"2025-09-12","current":-0.465964,"twenty":-4.197295,"median":-2.11268,"eighty":-0.876852,"marketCap":57577285},{"date":"2025-09-19","current":-0.402104,"twenty":-4.178393,"median":-2.097025,"eighty":-0.869983,"marketCap":49686422},{"date":"2025-09-26","current":-0.467367,"twenty":-4.162571,"median":-2.082501,"eighty":-0.859744,"marketCap":57750711},{"date":"2025-10-03","current":-0.441402,"twenty":-4.136838,"median":-2.059833,"eighty":-0.852257,"marketCap":54542338},{"date":"2025-10-10","current":-0.40842,"twenty":-4.110409,"median":-2.031663,"eighty":-0.841527,"marketCap":50466837},{"date":"2025-10-17","current":-0.423157,"twenty":-4.087399,"median":-2.015323,"eighty":-0.828364,"marketCap":52287806},{"date":"2025-10-24","current":-0.434385,"twenty":-4.048591,"median":-1.980827,"eighty":-0.8194,"marketCap":53675210},{"date":"2025-10-31","current":-0.768209,"twenty":-4.035263,"median":-1.924543,"eighty":-0.814808,"marketCap":94924556},{"date":"2025-11-07","current":-0.71421,"twenty":-4.001921,"median":-1.893677,"eighty":-0.800042,"marketCap":89005572},{"date":"2025-11-14","current":-0.75252,"twenty":-3.983807,"median":-1.863937,"eighty":-0.787249,"marketCap":93779818},{"date":"2025-11-21","current":-0.788094,"twenty":-3.966625,"median":-1.80015,"eighty":-0.784283,"marketCap":98213045},{"date":"2025-11-28","current":-0.768939,"twenty":-3.952294,"median":-1.769857,"eighty":-0.774404,"marketCap":95825923},{"date":"2025-12-05","current":-0.808617,"twenty":-3.936806,"median":-1.738822,"eighty":-0.768355,"marketCap":100770677},{"date":"2025-12-12","current":-0.957753,"twenty":-3.920106,"median":-1.702747,"eighty":-0.768355,"marketCap":119356132},{"date":"2025-12-19","current":-0.871555,"twenty":-3.906704,"median":-1.645027,"eighty":-0.768355,"marketCap":108614080},{"date":"2025-12-26","current":-1.022059,"twenty":-3.900594,"median":-1.598129,"eighty":-0.768355,"marketCap":127370043},{"date":"2026-01-02","current":-1.007009,"twenty":-3.882973,"median":-1.518763,"eighty":-0.768355,"marketCap":125494447},{"date":"2026-01-09","current":-1.2004,"twenty":-3.860185,"median":-1.463265,"eighty":-0.768355,"marketCap":149595012},{"date":"2026-01-16","current":-0.978539,"twenty":-3.835167,"median":-1.428644,"eighty":-0.768355,"marketCap":121946484},{"date":"2026-01-23","current":-0.9756,"twenty":-3.827408,"median":-1.378071,"eighty":-0.768355,"marketCap":121580279},{"date":"2026-01-30","current":-0.974131,"twenty":-3.803157,"median":-1.352845,"eighty":-0.768355,"marketCap":121397176},{"date":"2026-02-06","current":-0.89479,"twenty":-3.785183,"median":-1.314386,"eighty":-0.768355,"marketCap":111509623}],"updateTime":1770627196670},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KPTI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609301443","title":"Karyopharm Therapeutics Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2609301443","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609301443?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:55","pubTimestamp":1770303300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KPTI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2026 09:55 ET (14:55 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI"],"gpt_icon":0},{"id":"2609771153","title":"Karyopharm Therapeutics Inc. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht","url":"https://stock-news.laohu8.com/highlight/detail?id=2609771153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609771153?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:31","pubTimestamp":1770294708,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL5VZttV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2609373243","title":"Karyopharm initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2609373243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609373243?lang=en_us&edition=fundamental","pubTime":"2026-02-05 18:10","pubTimestamp":1770286210,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Yanni Souroutzidis initiated coverage of Karyopharm (KPTI) with an Overweight rating. The firm cites its probability-weig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/karyopharm-initiated-with-an-overweight-at-cantor-fitzgerald-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/karyopharm-initiated-with-an-overweight-at-cantor-fitzgerald-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2608890140","title":"BRIEF-Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2608890140","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608890140?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:15","pubTimestamp":1770066937,"startTime":"0","endTime":"0","summary":"BRIEF-Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing RuleFeb 2 (Reuters) - Karyopharm Therapeutics Inc KPTI.O:KARYOPHARM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LIS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA27NWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2608890584","title":"Karyopharm Therapeutics Grants RSUs to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2608890584","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608890584?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:06","pubTimestamp":1770066373,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has granted a total of 1,799 restricted stock units  to four newly hired employees. The RSUs will vest over three years, with one-third of the shares vesting on each anniversary of the grant date, contingent on continued employment with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on February 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL5zqfrk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2605241784","title":"Kristin Abate, Chief Accounting Officer, Reports Sale of Karyopharm Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605241784","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605241784?lang=en_us&edition=fundamental","pubTime":"2026-01-23 05:09","pubTimestamp":1769116199,"startTime":"0","endTime":"0","summary":"Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL8KWNLh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kristin Abate, Chief Accounting Officer, Reports Sale of Karyopharm Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2605531724","title":"Analysts Are Bullish on These Healthcare Stocks: Intuitive Surgical (ISRG), Karyopharm Therapeutics (KPTI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605531724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605531724?lang=en_us&edition=fundamental","pubTime":"2026-01-22 10:20","pubTimestamp":1769048415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG – Research Report) and Kary...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-intuitive-surgical-isrg-karyopharm-therapeutics-kpti-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-intuitive-surgical-isrg-karyopharm-therapeutics-kpti-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0061475181.USD","LU0354030511.USD","LU2063271972.USD","LU0823416689.USD","LU1951198990.SGD","LU0128526141.USD","BK4548","ISRG","LU0029874061.USD","LU0823434740.USD","LU2023250843.SGD","BK4504","BK4112","BK4534","BK4137","LU1989764748.USD","LU0354030438.USD","LU0097036916.USD","LU1989764664.SGD","LU1951200564.SGD","BK4585","LU0289739699.SGD","LU1923622614.USD","LU0096364046.USD","LU2023250504.SGD","BK4581","LU1917777945.USD","LU2106854487.HKD","LU2265009873.SGD","LU2433249047.HKD","LU1057294990.SGD","XBI","LU1061106388.HKD","IE00B19Z9505.USD","LU0114720955.EUR","LU0882574055.USD","LU1868836757.USD","LU1023059063.AUD","LU1804176565.USD","LU1923623000.USD","LU1868837136.USD","KPTI","BK4139","IE00BFXG0V08.USD","LU2125909593.SGD","LU0058720904.USD","LU1366192091.USD","LU0079474960.USD","LU0122379950.USD","LU1868836914.USD","LU0390134368.USD","LABU","LU1868836591.USD","LU2112291526.USD","LU2125909247.SGD","LU1983299246.USD","LU1974910355.USD","BK4588","LU0238689110.USD","LU1868837300.USD","LU2324357040.USD","BK4082","IE00B19Z8W00.USD","IE00BYQQ9H92.USD","LU0823434583.USD","IE00B19Z8X17.USD","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2604191491","title":"RBC Raises Price Target on Karyopharm Therapeutics to $23 From $19, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2604191491","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604191491?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:10","pubTimestamp":1768918254,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics (KPTI) has an average rating of overweight and mean price target of $15.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KPTI"],"gpt_icon":0},{"id":"2603542852","title":"Karyopharm Therapeutics Releases Updated Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542852?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:27","pubTimestamp":1768235276,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL9P4lpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2602751263","title":"Karyopharm sees FY25 revenue $145M, consensus $147.83M","url":"https://stock-news.laohu8.com/highlight/detail?id=2602751263","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602751263?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:17","pubTimestamp":1768220242,"startTime":"0","endTime":"0","summary":"Sees FY25 U.S. Xpovio net product revenue $115M. “2026 has the promise to be a transformative year for Karyopharm (KPTI) and the patient communitie...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/karyopharm-sees-fy25-revenue-145m-consensus-147-83m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/karyopharm-sees-fy25-revenue-145m-consensus-147-83m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2602514006","title":"Karyopharm Therapeutics Showcases Pipeline Progress and Selinexor Phase 3 Trial Milestones in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2602514006","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602514006?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:11","pubTimestamp":1768219907,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has released a corporate presentation highlighting key updates on its lead asset, XPOVIO . The company reports that XPOVIO/NEXPOVIO is now approved in over 50 countries and is being investigated in multiple cancer indications. Notable upcoming milestones include the expected release of top-line data from the Phase 3 SENTRY trial of selinexor in myelofibrosis in March 2026 and from the Phase 3 XPORT-EC-042 trial in endometrial cancer in mid-2026. The presentation also outlines the company's commercial capabilities in the U.S. and the potential for expansion into additional indications. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Thera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLcbdnN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2602932514","title":"Karyopharm Therapeutics forecasts 2025 revenue of $145 million with $115 million from XPOVIO sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2602932514","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602932514?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:01","pubTimestamp":1768219305,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has announced its preliminary unaudited financial outlook for 2025, projecting total revenue of approximately $145 million and U.S. XPOVIO  net product revenue of about $115 million for the full year. The company aims to maintain its commercial presence in the increasingly competitive multiple myeloma market and drive further growth in XPOVIO revenues. Karyopharm also continues to support global launches of selinexor in ex-U.S. territories and is preparing for upcoming potential regulatory filings and commercialization efforts, particularly with anticipated transformative clinical trial data expected in 2026. No significant variations in business performance for the disclosed period were highlighted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL1kpt4X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2602351413","title":"Karyopharm Therapeutics Inc - 2025 Revenue Expected at $145 Mln, U.S. Xpovio Revenue at $115 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2602351413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602351413?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:00","pubTimestamp":1768219212,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA9LPVCD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2602514456","title":"Press Release: Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602514456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602514456?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:00","pubTimestamp":1768219200,"startTime":"0","endTime":"0","summary":"-- Top-Line Data from the Phase 3 SENTRY Trial in Myelofibrosis on Track for March 2026 --. -- Preliminary Unaudited Full Year 2025 Total Revenue and U.S. XPOVIO   Net Product Revenue Expected to be Approximately $145 Million and $115 Million, Respectively --. \"2026 has the promise to be a transformative year for Karyopharm and the patient communities that we intend to serve, with top-line data from our Phase 3 SENTRY trial in myelofibrosis expected in March. Positive data from our SENTRY trial could unlock our opportunity to improve patient outcomes and redefine the standard-of-care in myelofibrosis. Our teams are actively preparing for regulatory filings, commercialization and the opportunity to rapidly launch with the first ever combination therapy in a multi-billion dollar market,\" said Richard Paulson, President and Chief Executive Officer of Karyopharm. \"In endometrial cancer, we remain focused and on track to report top-line data from our Phase 3 XPORT-EC-042 trial in mid-2026, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054578231.USD","KPTI","ITT","R","BK4139","BK4022","BK4161","BK4232","LU0053671581.USD"],"gpt_icon":0},{"id":"2602386301","title":"Karyopharm Therapeutics Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2602386301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602386301?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:16","pubTimestamp":1767993403,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. will hold a Special Meeting of Stockholders on February 18, 2026. During the meeting, stockholders will vote on proposals regarding the authorization of additional shares and the potential adjournment of the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL7NBzg6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2600709564","title":"Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2600709564","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600709564?lang=en_us&edition=fundamental","pubTime":"2026-01-03 06:24","pubTimestamp":1767392678,"startTime":"0","endTime":"0","summary":"Jan 2 (Reuters) - Karyopharm Therapeutics Inc ::*KARYOPHARM THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 02-JAN-202621:05:00.05 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nRSD34Rg70:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2600098209","title":"Karyopharm Therapeutics Grants RSUs to New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600098209?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:05","pubTimestamp":1767387921,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has granted a total of 1,533 restricted stock units  to two newly-hired employees. These RSUs were awarded as of December 31, 2025, under the company’s 2022 Inducement Stock Incentive Plan. Each RSU award will vest over three years, with one-third of the shares vesting on each of the three consecutive anniversaries of the grant date, contingent on the recipient's continued employment or service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on January 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL9zd3p9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2595671723","title":"Karyopharm Therapeutics Inc. Announces Date for Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2595671723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595671723?lang=en_us&edition=fundamental","pubTime":"2025-12-31 05:14","pubTimestamp":1767129279,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has scheduled a special meeting of stockholders to be held on February 18, 2026. During the meeting, shareholders will consider and vote on a proposal to adopt and approve an amendment to the company’s Restated Certificate of Incorporation to increase the number of authorized shares. Additionally, stockholders will vote on a proposal related to the possible adjournment of the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL16vHz9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KPTI"],"gpt_icon":0},{"id":"2589337703","title":"Karyopharm Therapeutics Joins Baird's Biotech Discovery Series Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337703","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337703?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:01","pubTimestamp":1765195268,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. will participate in a virtual fireside chat as part of Baird's Biotech Discovery Series on Wednesday, December 10, 2025, at 12:00 p.m. ET. The event will feature the company's senior management team and Dr. Claire Harrison, a leading expert in myelofibrosis. A live webcast will be available on the company's investor relations website, with a replay accessible after the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on December 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDLJ8bwc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0},{"id":"2588708770","title":"Karyopharm Therapeutics Grants Stock Options and RSUs to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2588708770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588708770?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:05","pubTimestamp":1764623130,"startTime":"0","endTime":"0","summary":"Karyopharm Therapeutics Inc. has granted stock options to purchase a total of 2,800 shares of its common stock and 15,791 restricted stock units  to seven newly-hired employees. The stock options, with an exercise price of $5.62 per share, vest over four years, with 25% vesting on the one-year anniversary of the employee's start date and the remainder vesting monthly thereafter. Each RSU award will vest over three years, with one-third vesting on each anniversary of the grant date. Vesting for both stock options and RSUs is contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karyopharm Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on December 01, 2025, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL3MK8t8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPTI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}]}}